Q2 2020 Evofem Biosciences Inc Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to the Evofem Biosciences Second Quarter 2020 Financial Results Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded (Operator Instructions)
I would now like to hand the conference over to your speaker today, Ms. Amy Raskopf, Evofem Biosciences Head of Investor Relations. Ma'am, please go ahead.
Thank you, and good morning, everyone. Welcome to the Evofem Biosciences Q2 conference call. If you haven't done so already, I encourage you to access the Q2 2020 presentation and the press release we issued earlier today, both of which are at evofem.com under the Investors tab.
Before we begin, I would like to remind you that remarks on this call will contain forward-looking statements, which are made only as of today, August 4, 2020. For a more detailed description of important risk factors that could cause our actual results to differ materially, please refer to our annual report on Form 10
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |